ClinicalTrials.gov
ClinicalTrials.gov Menu

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00382070
Recruitment Status : Active, not recruiting
First Posted : September 28, 2006
Last Update Posted : May 5, 2017
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Novartis
Information provided by (Responsible Party):
NSABP Foundation Inc